Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John B Porter

Showing results (31-40 of 125) with videos related to

Pageof 13
Sort By:
American Journal of Hematology|October 23, 2018
Predicting serum ferritin levels in patients with iron overload treated with the film-coated tablet of deferasirox during the ECLIPSE studyAli T Taher, Sebastian Weber, Jackie Han, et al.
Haematologica|June 24, 2017
Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrinMaciej W Garbowski, Patricia Evans, Evangelia Vlachodimitropoulou, et al.
Hemoglobin|January 6, 2012
Secondary erythrocytosis due to compound homozygosity, but not compound heterozygosity, for Hb Luton and α-thalassemia: a family studyDima El-Sharkawi, Chris Fisher, Sachin Khambadkone, et al.
Nuclear Medicine Communications|June 4, 2024
Bone mineral density in adult thalassaemias: a retrospective longitudinal studySarah Algodayan, Ramya Balachandar, Nikolaos Papathanasiou, et al.
Drug Design, Development and Therapy|December 24, 2016
Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromesAli T Taher, John B Porter, Antonis Kattamis, et al.
Molecules (Basel, Switzerland)|May 31, 2020
Phytosterol, Lipid and Phenolic Composition, and Biological Activities of Guava Seed OilAdchara Prommaban, Niramon Utama-Ang, Anan Chaikitwattana, et al.
Pancreas|May 16, 2019
Decrement in Cellular Iron and Reactive Oxygen Species, and Improvement of Insulin Secretion in a Pancreatic Cell Line Using Green Tea ExtractPimpisid Koonyosying, Chairat Uthaipibull, Suthat Fucharoen, et al.
Journal of Medicinal Chemistry|January 25, 2002
Design, synthesis, and evaluation of novel 2-substituted 3-hydroxypyridin-4-ones: structure-activity investigation of metalloenzyme inhibition by iron chelatorsZu D Liu, Reem Kayyali, Robert C Hider, et al.
British Journal of Sports Medicine|October 4, 2011
Sudden exertional death in sickle cell traitMike Loosemore, Stephen B Walsh, Emma Morris, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|June 27, 2016
Clinical and methodological factors affecting non-transferrin-bound iron values using a novel fluorescent bead assayMaciej W Garbowski, Yongmin Ma, Suthat Fucharoen, et al.
Pageof 13

Showing results (31-40 of 125) with videos related to

Sort By:
Pageof 13
American Journal of Hematology|October 23, 2018
Predicting serum ferritin levels in patients with iron overload treated with the film-coated tablet of deferasirox during the ECLIPSE studyAli T Taher, Sebastian Weber, Jackie Han, et al.
Haematologica|June 24, 2017
Residual erythropoiesis protects against myocardial hemosiderosis in transfusion-dependent thalassemia by lowering labile plasma iron via transient generation of apotransferrinMaciej W Garbowski, Patricia Evans, Evangelia Vlachodimitropoulou, et al.
Hemoglobin|January 6, 2012
Secondary erythrocytosis due to compound homozygosity, but not compound heterozygosity, for Hb Luton and α-thalassemia: a family studyDima El-Sharkawi, Chris Fisher, Sachin Khambadkone, et al.
Nuclear Medicine Communications|June 4, 2024
Bone mineral density in adult thalassaemias: a retrospective longitudinal studySarah Algodayan, Ramya Balachandar, Nikolaos Papathanasiou, et al.
Drug Design, Development and Therapy|December 24, 2016
Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromesAli T Taher, John B Porter, Antonis Kattamis, et al.
Molecules (Basel, Switzerland)|May 31, 2020
Phytosterol, Lipid and Phenolic Composition, and Biological Activities of Guava Seed OilAdchara Prommaban, Niramon Utama-Ang, Anan Chaikitwattana, et al.
Pancreas|May 16, 2019
Decrement in Cellular Iron and Reactive Oxygen Species, and Improvement of Insulin Secretion in a Pancreatic Cell Line Using Green Tea ExtractPimpisid Koonyosying, Chairat Uthaipibull, Suthat Fucharoen, et al.
Journal of Medicinal Chemistry|January 25, 2002
Design, synthesis, and evaluation of novel 2-substituted 3-hydroxypyridin-4-ones: structure-activity investigation of metalloenzyme inhibition by iron chelatorsZu D Liu, Reem Kayyali, Robert C Hider, et al.
British Journal of Sports Medicine|October 4, 2011
Sudden exertional death in sickle cell traitMike Loosemore, Stephen B Walsh, Emma Morris, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|June 27, 2016
Clinical and methodological factors affecting non-transferrin-bound iron values using a novel fluorescent bead assayMaciej W Garbowski, Yongmin Ma, Suthat Fucharoen, et al.
Pageof 13